CTOS 14th
Annual Meeting
November 13–15, 2008
London, United Kingdom
Schedule: Thursday | Friday | Saturday
Download PDF Version with Abstracts
Thursday, November 13, 2008 |
|
07:00 - 08:00 |
Registration and Poster Set-Up |
|
|
08:00 - 12:00 |
|
|
||
09:00 - 12:00 |
||
|
11 |
#34981 MAGNETIC RESONANCE SIMULATION (SMR) FOR LOWER EXTREMITY
SOFT TISSUE SARCOMA (LE-STS) PATIENTS TREATED WITH PRE-OPERATIVE |
|
11 |
#35042 A RETROSPECTIVE STUDY COMPARING INITIAL GP DATA ON TWO WEEK
WAIT REFERRALS WITH CLINICAL REVIEW AND IMAGING AT A SPECIALIST
CENTRE |
|
11 |
#35081 COLLABORATIVE MANAGEMENT OF SARCOMA PATIENTS IN 2008:
INTEGRATING IMPROVEMENTS IN CARE FROM NOVEL THERAPIES TO
DEVELOPMENT OF NEW RESOURCES |
|
11 |
#35090 CARE OF THE INTERNATIONAL PEDIATRIC PATIENT AND FAMILY - THE
PUERTO RICO PATIENT ASSISTANCE PROGRAM |
|
12 |
#35092 EXAMINING ONE SARCOMA CENTER’S EXPERIENCE WITH SUCCESSFUL
RECRUITMENT TO RANDOMIZED, PLACEBO CONTROLLED CLINICAL TRIALS |
| THE USE OF NON-INVASIVE EXTENDING ENDOPROSTHES FOLLOWING FAILED
ALLOGRAFT SURGERY IN SKELETALLY MATURE PATIENTS Chris Henry |
||
|
|
09:00 - 12:00 |
Patient Advocacy Groups Meeting |
|
|
13:30 - 13:40 |
Introduction to 14th Annual Meeting |
|
||
13:40 - 14:30 |
Molecular Pathology of Sarcomas |
|
|
12 |
#34879 PROGNOSTIC VALUE OF MYOGENIC DIFFERENTIATION IN ADULT SOFT
TISSUE SARCOMAS. A STUDY OF 855 CASES FROM THE FRENCH SARCOMA |
|
12 |
#34956 GENE EXPRESSION PROFILE OF POORLY DIFFERENTIATED SYNOVIAL
SARCOMA |
|
13 |
#35080 GROWTH FACTORS AND PATHWAY ACTIVATION IN CHORDOMA |
|
13 |
#35032 RECURRENT CHROMOSOMAL COPY NUMBER ALTERATIONS IN
CHORDOMA |
|
||
14:30 - 15:30 |
Gynecological Sarcomas |
|
|
13 |
#34982 STAGE SPECIFIC OUTCOMES OF PATIENTS WITH UTERINE
LEIOMYOSARCOMA: A COMPARISON OF FIGO AND AJCC STAGING SYSTEMS |
|
14 |
#34970 PREDICTIVE VALUE OF FIGO AND AJCC STAGING SYSTEMS IN 230
PATIENTS (PTS) WITH UTERINE LEIOMYOSARCOMA (ULMS): IS IT TIME FOR A |
|
14 |
#34855 WILMS’ TUMOR GENE 1 (WT1) IS A NEW PROGNOSTIC MARKER IN HIGH
GRADE UTERINE SARCOMA |
|
15 |
#34961 ADJUVANT GEMCITABINE PLUS DOCETAXEL FOR COMPLETELY
RESECTED STAGE I-IV HIGH GRADE UTERINE LEIOMYOSARCOMA: RESULTS
OF A PHASE II TRIAL |
| 15 | #35073 CLINICAL FEATURES AND OUTCOME IN OVARIAN SARCOMAS: ANALYSIS
OF A SINGLE-INSTITUTION EXPERIENCE Antonio Lopez Pousa; X. Gonzalez; M.J. Quintana; S. Bague; O. Gallego; A. Tibau; J. Perez Altoyano; N. Sala; J.M. Mazarico; V. Artigas; A. Barnadas |
|
|
|
15:30 - 16:15 |
Tea and Poster Viewing |
|
|
16:15 - 16:30 |
Poster Discussion 1 |
|
||
16:30 - 18:00 |
Fibromatosis:
Biology & Multidisciplinary Management |
|
|
15 |
#34875 ALTERNATIVE CLINICAL APPROACH IN AGGRESSIVE FIBROMATOSIS:
WAIT & SEE FRONTLINE POLICY. A MULTI-INSTITUTIONAL RETROSPECTIVE
REVIEW |
|
16 |
#35006 DESMOID TUMOURS: TO OPERATE OR NOT TO OPERATE |
|
16 |
#34885 THE DESMOID TUMOR PROTEOME; IDENTIFYING MOLECULAR
MARKERS USING A CLINICALLY ANNOTATED TISSUE MICROARRAY |
|
16 |
#35119 MESENCHYMAL PROGENITOR CELLS ARE INVOLVED IN THE
FORMATION OF AGGRESSIVE FIBROMATOSIS (DESMOID TUMOR) |
|
17 |
#34904 MULTIMODALITY TREATMENT OF MESENTERIC DESMOID TUMORS |
|
17 |
#35057 ACTIVITY OF MEDICAL THERAPY (METHOTREXATE + VINBLASTINE/
VINORELBINE OR TAMOXIFEN) IN DESMOID FIBROMATOSIS (DF):
RETROSPECTIVE ANALYSIS OF 79 PATIENTS FROM A SINGLE INSTITUTION |
|
17 |
#34852 SUCCESSFUL TREATMENT OF FIBROMATOSIS WITH HYDROXYUREA:
ANALYSIS OF 20 PEDIATRIC CASES |
Friday, November 14, 2008 |
07:00 - 08:00 |
Executive Committee Meeting |
|
||
08:00 - 09:00 |
Surgery |
|
|
36 |
#34880 MORBIDITY OF AN UNPLANNED EXCISION OF SOFT TISSUE SARCOMAS: A
QUANTITATIVE ASSESSMENT |
|
37 |
#34876 MARGINAL SURGERY IN PRIMARY EXTREMITY SOFT TISSUE SARCOMA:
PROGNOSTIC ROLE OF ANATOMIC BARRIER AT CLOSEST SURGICAL MARGIN |
|
37 |
#34869 CLINICAL VARIABLES, PATHOLOGICAL FACTORS, AND MOLECULAR
MARKERS FOR ENHANCED SOFT TISSUE SARCOMA PROGNOSTICATION |
|
38 |
#35066 PROGNOSTIC FACTORS FOR LONG-TERM SURVIVAL AFTER PULMONARY
METASTASECTOMY IN SARCOMA PATIENTS: A 16 -YEAR EXPERIENCE |
|
38 |
#34860 ROLE OF SENTINEL LYMPH NODE BIOPSY IN THE STAGING OF
SYNOVIAL, EPITHELIOID, AND CLEAR CELL SARCOMAS |
|
||
09:00 - 10:00 |
Bone Sarcomas 1- Pediatric Oncology |
|
|
38 |
#34849 THE MORE IT HURTS, THE BETTER IT WORKS? CHEMOTHERAPY
TOXICITY AS A PREDICTOR OF OUTCOME FROM OSTEOSARCOMA: A REPORT
FROM THE EUROPEAN OSTEOSARCOMA INTERGROUP |
|
39 |
#35051 CHANGE IN ANATOMIC DISTRIBUTION OF RELAPSES WITH
ACCELERATED CHEMOTHERAPY IN EWING SARCOMA |
|
39 |
#35047 THE VALUE OF LOCAL TREATMENT IN PATIENTS WITH
EXTRAPULMONARY METASTAZISED EWING TUMORS (EPMET) |
|
39 |
#35094 ACTIVITY OF SCH 717454 IN SUBJECTS WITH RELAPSED OSTEOSARCOMA
OR EWING’S SARCOMA (STUDY P04720) |
|
40 |
#34973 ADDITION OF PAMIDRONATE TO CHEMOTHERAPY FOR TREATMENT OF
OSTEOSARCOMA (OS) IS FEASIBLE |
|
|
10:00 - 10:30 |
Coffee Break & Poster Viewing |
|
||
10:30 - 11:45 |
NF1: MPNST and Other Sarcomas, Diagnosis & Treatment |
|
|
40 |
#35059 18FDG PET/CT IN THE DIAGNOSIS OF MALIGNANT PERIPHERAL NERVE
SHEATH TUMOURS |
|
40 |
#35152 GENETIC ANALYSIS OF PERIPHERAL NERVE SHEATH TUMOURS IN NF1
PATIENTS |
|
41 |
#34868 MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST): CLINICAL,
PATHOLOGIC AND MOLECULAR PREDICTORS OF SURVIVAL |
|
41 |
#35055 MICROARRAY GENE EXPRESSION DATA UTILIZED TO IDENTIFY
PUTATIVE SERUM BIOMARKERS OF NEUROFIBROMATOSIS TYPE 1 ASSOCIATED
TUMORS |
|
41 |
#35072 GASTROINTESTINAL STROMAL TUMOR (GIST) IN NEUROFIBROMATOSIS
1 (NF1) PATIENTS: A CLINICOPATHOLOGIC ANALYSIS OF NINE CASES |
|
41 |
#34974 NUCLEAR TP53 EXPRESSION IN MALIGNANT PERIPHERAL NERVE
SHEATH TUMOURS IS AN INDEPENDENT MARKER OF POOR SURVIVAL |
|
|
11:45 - 12:45 |
Herman Suit Lecture – Professor Ivan Stamenkovic,
|
|
|
12:45 - 14:00 |
Board of Directors Meeting |
|
||
14:00 - 15:00 |
Radiation Oncology |
|
|
42 |
#35069 ADEQUATE 3D TREATMENT VOLUME IN PREOPERATIVE RADIOTHERAPY
IN EXTREMITY SOFT TISSUE SARCOMA |
|
42 |
#35029 HYPOXIA IN RESECTABLE SOFT-TISSUE SARCOMAS ON FUNCTIONAL
IMAGING WITH [18F]-FLUOROAZOMYCIN ARABINOSIDE POSITRON EMISSION
TOMOGRAPHY POWERFULLY PREDICTS POOR RESPONSE TO RADIOTHERAPY
AND EARLY RELAPSE |
|
43 |
#35012 CARBON ION RADIOTHERAPY FOR SACRAL CHORDOMA |
|
43 |
#35038 LONG-TERM FOLLOW-UP OF A PROSPECTIVE TRIAL OF PRE-OPERATIVE
EXTERNAL-BEAM RADIATION AND POST-OPERATIVE BRACHYTHERAPY FOR
RETROPERITONEAL SARCOMA |
|
43 |
#34907 EFFECTIVENESS OF RADIOTHERAPY IN MYXOID SARCOMAS IS
ASSOCIATED WITH A DENSE VASCULAR PATTERN |
|
||
15:00 - 16:00 |
Biology 1 - Molecular Biology of Sarcomas |
|
|
44 |
#35046 MULTIFOCAL MYXOID LIPOSARCOMA; METASTASIS OR SECOND
PRIMARY? A MOLECULAR BIOLOGICAL ANALYSIS. |
|
44 |
#35068 HUMAN MONOCLONAL ANTIBODY R1507 INHIBITS GROWTH OF
OSTEOSARCOMA XENOGRAFTS AND IS EFFECTIVE IN COMBINATION WITH
RAPAMYCIN |
|
44 |
#34955 EWS/FLI REGULATES NKX2.2 VIA GLI IN A NON-SHH-DEPENDENT
MANNER |
|
45 |
#35143 GLI2 AND P53 COOPERATE TO REGULATE IGFBP-3 MEDIATED CHONDROCYTE APOPTOSIS IN THE PROGRESSION FROM BENIGN TO MALIGNANT CARTILAGE TUMOURS Louisa Ho; Aneta Stojanovski; Heather Whetstone; Qingxia Wei; Elaine Mau Elaine Mau; Benjamin Alman; Jay Wunder |
|
45 |
#35037 OSTEOCHONDROMAGENESIS: SOMATIC LOSS OF HETEROZYGOSITY
MODELED VIA CRE-MEDIATED INVERSION OF THE SECOND EXON OF EXT1 IN
CHONDROCYTES |
|
|
16:00 - 16:45 |
Afternoon Break & Poster Viewing |
|
||
16:45 - 17:00 49 |
Poster Session 2 34593, 34800, 34807, 34819, 34825, 34827, 34839, 34840, 34859, 34861, 34864, 34867, 34913, 34934, 34939, 34942, 34949, 34951, 34967, 34969, 34986, 34988, 34993, 34995, 35013, 35026, 35030, 35031, 35035, 35039, 35063, 35074, 35083, 35087, 35089, 35091, 35098, 35099, 35100, 35101, 35103, 35105, 35107, 35108, 35111, 35112, 35125, 35128, 35134, 35137, 35139, 35148, 35160 |
|
|
||
17:00 - 17:30 |
|
|
|
45 |
THE SARC CAREER DEVELOPMENT AWARD |
|
||
17:00 - 17:30 |
Young Investigator Award Lectures |
|
|
46 |
#35020 SOFT TISSUE SARCOMA (STS) OF THE EXTREMITY - COMPARISON
OF CONFORMAL POST-OPERATIVE RADIOTHERAPY (CRT) AND INTENSITY
MODULATED RADIOTHERAPY (IMRT) |
|
46 |
#34891 PFETIN AS A PROGNOSTIC BIOMARKER OF GASTROINTESTINAL
STROMAL TUMORS REVEALED BY PROTEOMICS |
|
|
17:30 - 18:00 |
Members Business Meeting |
|
|
|
|
Saturday, November 15, 2008 |
|
||
08:00 - 09:00 |
Medical Oncology |
|
|
65 |
#35064 COMBINATION THERAPY WITH TEMOZOLOMIDE AND BEVACIZUMAB
(TMZ/BV) IN THE TREATMENT OF EMANGIOPERICYTOMA/SOLITARY FIBROUS
TUMOR (HPC/SFT): AN UPDATED ANALYSIS. |
|
65 |
#34936 ACTIVITY OF THE VEGFR/KIT TYROSINE KINASE INHIBITOR CEDIRANIB
(AZD2171) IN ALVEOLAR SOFT PART SARCOMA. |
|
65 |
#35024 ADVANCED CHORDOMA FOLLOWING IMATINIB (IM) RESISTANCE |
|
65 |
#35085 RESPONSES TO THE MTOR INHIBITOR SIROLIMUS IN PATIENTS WITH
MALIGNANT PECOMA: REPORT OF THREE CASES |
|
66 |
#35067 A PHASE II STUDY OF INTRAVENOUS REOLYSIN (WILD TYPE REOVIRUS)
IN THE TREATMENT OF PATIENTS WITH BONE AND SOFT TISSUE SARCOMAS
METASTATIC TO THE LUNG |
|
||
09:00 - 09:30 |
Diagnostic Techniques |
|
|
66 |
#34828 PERCUTANEOUS CT-GUIDED BIOPSY OF THE MUSCOLO-SKELETAL
SYSTEM: RESULTS OF 1722 CASES |
|
66 |
#35076 CORE NEEDLE BIOPSY IS HIGHLY ACCURATE IN DIAGNOSING BONE AND
SOFT-TISSUE TUMOURS |
|
67 |
#35016 PRELIMINARY EXPERIENCE USING PET-CT IN SUSPECTED PEDIATRIC
BONE AND SOFT TISSUE SARCOMAS |
|
||
09:30 - 10:30 |
Bone Sarcomas 2 - Surgery and Molecular Biology |
|
|
67 |
#34854 FREE VASCULARIZED FIBULAR GRAFTING FOR MALIGNANT BONE AND
SOFT TISSUE TUMOR: RADIOLOGICAL, CLINICAL AND FUNCTIONAL OUTCOME |
|
67 |
#34914 COMPLIANT FIXATION OF MEGA-NDOPROSTHETICS: RESULTS OF
VARIED APPLICATIONS |
|
68 |
#35000 LENTIVIRAL SHRNA SCREEN OF HUMAN KINASES IDENTIFIES NEW
REGULATORS OF OSTEOSARCOMA CELL SURVIVAL AND APOPTOSIS |
|
68 |
#35116 A NOVEL PROFILING STRATEGY IN OSTEOSARCOMA IDENTIFIES EBF2 AS
A MEDIATOR OF OPG INHIBITION TO TRAIL-INDUCED APOPTOSIS |
|
68 |
#35140 NEW SURGICAL TECHNIQUE TO REDUCE DISLOCATIONS OF PROXIMAL
AND TOTAL HUMERUS REPLACEMENTS AFTER TUMOR RESECTION |
|
|
10:30 - 11:00 |
Coffee Break & Poster Viewing |
|
|
11:00 - 12:00 |
Nina Axelrad Lecture – Paul Myers –
|
|
||
13:30 - 14:30 |
Biology 2 - New Targets - Molecular Biology &
Therapy |
|
|
69 |
#35145 COMBINATION PI3K/MTOR INHIBITION LIMITS CHORDOMA
PROLIFERATION |
|
69 |
#35008 THE PROTEOLYTIC MACHINERY AS NOVEL THERAPEUTIC TARGET IN
GASTROINTESTINAL STROMAL TUMORS (GISTS) |
|
69 |
#34962 EGR1 MEDIATES HISTONE DEACETYLASE SENSITIVITY IN SYNOVIAL
SARCOMA VIA THE PTEN TUMOR SUPPRESSOR |
|
70 |
#34884 THE C-MET RECEPTOR CONTRIBUTES TO MOTILITY AND INVASION IN
A BROAD RANGE OF STS HISTOLOGIES; A POTENTIAL ANTI-STS THERAPEUTIC
TARGET |
|
70 |
#35041 OVERCOMING RESISTANCE TO CONVENTIONAL DRUGS IN EWING’ S
SARCOMA AND IDENTIFICATION OF MOLECULAR PREDICTORS OF OUTCOME |
|
|
14:30 - 15:30 |
Sarcoma Cooperative Trials Groups Overview |
|
|
15:30 - 16:15 |
Afternoon Break and Poster Viewing |
|
|
16:15 - 16:30 |
Poster Discussion 3 34545, 34820, 34824, 34844, 34845, 34850, 34863, 34866, 34896, 34897, 34898, 34899, 34906, 34908, 34911, 34938, 34946, 34948, 34952, 34960, 34963, 34965, 34971, 34977, 34980, 34991, 35001, 35005, 35010, 35011, 35017, 35018, 35019, 35021, 35022, 35033, 35034, 35036, 35040, 35044, 35049, 35052, 35060, 35070, 35079, 35082, 35095, 35104, 35113, 35127, 35129, 35130, 35131, 35132, 35133, 35136, 35144, 35154, 35162, 35170 |


